T 0305/13 (Class II mannosidase/GLICOFY) of 26.02.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T030513.20190226
- Date of decision
- 26 February 2019
- Case number
- T 0305/13
- Petition for review of
- -
- Application number
- 04713372.3
- IPC class
- C12P 21/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- EXPRESSION OF CLASS II MANNOSIDASE AND CLASS III MANNOSIDASE IN LOWER EUKARYOTIC CELLS
- Applicant name
- GlycoFi, Inc.
- Opponent name
- Novartis AG
Lonza Ltd. & Lonza Biologics plc. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(3) 1973European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84
- Keywords
- Main request - meets the requirements of the EPC (yes)
- Catchword
- -
- Citing cases
- T 1289/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent on the basis of claims 1 to 20 according to the main request filed at the oral proceedings before the board on 26 February 2016 and a description to be adapted.